Publicaciones en las que colabora con FEDERICO GILBERTO HAWKINS CARRANZA (86)

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

2021

  1. Trabecular bone score and bone mineral density in patients with long-term controlled acromegaly

    Clinical Endocrinology, Vol. 95, Núm. 1, pp. 58-64

2020

  1. Association of Low Serum 25OHD Levels with Abnormal Bone Microarchitecture in Well-Differentiated Thyroid Cancer

    Medical sciences (Basel, Switzerland), Vol. 8, Núm. 4

  2. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy

    Cancer Medicine, Vol. 9, Núm. 16, pp. 5746-5755

2019

  1. Different development of serum sclerostin compared to other bone remodeling markers in the first year after a liver transplant

    Revista de Osteoporosis y Metabolismo Mineral

  2. Enfermedad metabólica ósea postrasplante

    Anales de la Real Academia Nacional de Medicina, Núm. 136, pp. 249-255

2018

  1. Farmacología del calcio y del hueso

    Velázquez. Farmacología básica y clínica (Editorial Médica Panamericana), pp. 647-656

  2. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy

    Endocrine, Vol. 62, Núm. 1, pp. 166-173

2017

  1. Thyroid hormones, TSH, thyroid cancer and bones in pre- and postmenopausal women

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 2, pp. 89-101

2016

  1. Recalcitrant hypocalcaemia in a patient with post-thyroidectomy hypoparathyroidism and Roux-en-Y gastric bypass

    Obesity Research and Clinical Practice, Vol. 10, Núm. 3, pp. 344-347

  2. Serum Levels of Osteocalcin and Insulin Resistance in Patients with Impaired Glucose Tolerance or New-Onset Diabetes Mellitus after Liver Transplantation

    Hormone and Metabolic Research, Vol. 48, Núm. 5, pp. 325-330

  3. Seven years of follow up of trabecular bone score, bone mineral density, body composition and quality of life in adults with growth hormone deficiency treated with rhGH replacement in a single center

    Therapeutic Advances in Endocrinology and Metabolism, Vol. 7, Núm. 3, pp. 93-100

  4. Trabecular bone score in patients with liver transplants after 1 year of risedronate treatment

    Transplant International, Vol. 29, Núm. 3, pp. 331-337

2013

  1. Bone mineral density and vitamin D levels in erythropoietic protoporphyria

    Endocrine, Vol. 44, Núm. 3, pp. 803-807

  2. Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial

    Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368

  3. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

    Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981

  4. Erratum: Bone mineral density and vitamin D levels in erythropoietic protoporphyria (Endocrine (DOI 10.1007/s12020-013-9934-x))

    Endocrine

  5. Hiperparatiroidismo primario normocalcémico: Un problema en aumento

    Medicina Clinica, Vol. 141, Núm. 3, pp. 125-129

2012

  1. Hipercalcemia

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 11, Núm. 16, pp. 934-943

  2. Hipercalcemia

    Medicine (Spain), Vol. 11, Núm. 16, pp. 934-943